Authors:
DURBIN AP
WYATT LS
SIEW J
MOSS B
MURPHY BR
Citation: Ap. Durbin et al., THE IMMUNOGENICITY AND EFFICACY OF INTRANASALLY OR PARENTERALLY ADMINISTERED REPLICATION-DEFICIENT VACCINIA-PARAINFLUENZA VIRUS TYPE-3 RECOMBINANTS IN RHESUS-MONKEYS, Vaccine, 16(13), 1998, pp. 1324-1330
Authors:
WYATT LS
CARROLL MW
CZERNY CP
MERCHLINSKY M
SISLER JR
MOSS B
Citation: Ls. Wyatt et al., MARKER RESCUE OF THE HOST-RANGE RESTRICTION DEFECTS OF MODIFIED VACCINIA VIRUS ANKARA, Virology (New York, N.Y. Print), 251(2), 1998, pp. 334-342
Authors:
SETH A
OURMANOV I
KURODA MJ
SCHMITZ JE
CARROLL MW
WYATT LS
MOSS B
FORMAN MA
HIRSCH VM
LETVIN NL
Citation: A. Seth et al., RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA-SIMIAN IMMUNODEFICIENCY VIRUS GAG POL ELICITS CYTOTOXIC T-LYMPHOCYTES IN RHESUS-MONKEYS DETECTEDBY A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I PEPTIDE TETRAMER, Proceedings of the National Academy of Sciences of the United Statesof America, 95(17), 1998, pp. 10112-10116
Authors:
BELYAKOV IM
WYATT LS
AHLERS JD
EARL P
PENDLETON CD
KELSALL BL
STROBER W
MOSS B
BERZOFSKY JA
Citation: Im. Belyakov et al., INDUCTION OF A MUCOSAL CYTOTOXIC T-LYMPHOCYTE RESPONSE BY INTRARECTALIMMUNIZATION WITH A REPLICATION-DEFICIENT RECOMBINANT VACCINIA VIRUS EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS-89.6 ENVELOPE PROTEIN, Journal of virology, 72(10), 1998, pp. 8264-8272
Citation: Ls. Wyatt et al., DEVELOPMENT OF A REPLICATION-DEFICIENT RECOMBINANT VACCINIA VIRUS-VACCINE EFFECTIVE AGAINST PARAINFLUENZA VIRUS 3 INFECTION IN AN ANIMAL-MODEL, Vaccine, 14(15), 1996, pp. 1451-1458
Authors:
KATSAFANAS GC
SCHIRMER EC
WYATT LS
FRENKEL N
Citation: Gc. Katsafanas et al., IN-VITRO ACTIVATION OF HUMAN HERPESVIRUS-6 AND HERPESVIRUS-7 FROM LATENCY, Proceedings of the National Academy of Sciences of the United Statesof America, 93(18), 1996, pp. 9788-9792
Authors:
BENDER BS
ROWE CA
TAYLOR SF
WYATT LS
MOSS B
SMALL PA
Citation: Bs. Bender et al., ORAL IMMUNIZATION WITH A REPLICATION-DEFICIENT RECOMBINANT VACCINIA VIRUS PROTECTS MICE AGAINST INFLUENZA, Journal of virology, 70(9), 1996, pp. 6418-6424
Authors:
SEVER JL
RAKUSAN TA
ELLAURIE M
FRENKEL N
WYATT LS
CAMPOS JM
ODONNELL RM
PRICE MV
Citation: Jl. Sever et al., COINFECTION WITH HERPESVIRUSES IN YOUNG-CHILDREN OF HIV-INFECTED WOMEN, Pediatric AIDS and HIV infection, 6(2), 1995, pp. 75-82
Authors:
BURNS JC
NEWBURGER JW
SUNDELL R
WYATT LS
FRENKEL N
Citation: Jc. Burns et al., SEROPREVALENCE OF HUMAN HERPESVIRUS-7 IN PATIENTS WITH KAWASAKI-DISEASE, The Pediatric infectious disease journal, 13(2), 1994, pp. 168-169
Authors:
FRENKEL N
KATSAFANAS GC
WYATT LS
YOSHIKAWA T
ASANO Y
Citation: N. Frenkel et al., BONE-MARROW TRANSPLANT RECIPIENTS HARBOR THE B-VARIANT OF HUMAN HERPESVIRUS-6, Bone marrow transplantation, 14(5), 1994, pp. 839-843
Authors:
SUTTER G
WYATT LS
FOLEY PL
BENNINK JR
MOSS B
Citation: G. Sutter et al., A RECOMBINANT VECTOR DERIVED FROM THE HOST RANGE-RESTRICTED AND HIGHLY ATTENUATED MVA STRAIN OF VACCINIA VIRUS STIMULATES PROTECTIVE IMMUNITY IN MICE TO INFLUENZA-VIRUS, Vaccine, 12(11), 1994, pp. 1032-1040
Authors:
YOSHIKAWA T
ASANO Y
KOBAYASHI I
NAKASHIMA T
YAZAKI T
SUGA S
OZAKI T
WYATT LS
FRENKEL N
Citation: T. Yoshikawa et al., SEROEPIDEMIOLOGY OF HUMAN HERPESVIRUS-7 IN HEALTHY-CHILDREN AND ADULTS IN JAPAN, Journal of medical virology, 41(4), 1993, pp. 319-323